Bank of America Merrill Lynch Reiterates Buy Rating, $70 PO on Baxter International

In a report published Wednesday, Bank of America Merrill Lynch reiterated its Buy rating and $70 price objective on Baxter International (NYSE: BAX ). BofA Merrill Lynch noted, “Some reasons we see to own BAX are: 1) The core markets Baxter's bioscience business competes in have attractive fundamentals that should